In this episode, Richard Steinfeld interviews Suresh Dheerendra, Senior Vice President of Clinical Operations at Neuron 23. They discuss the complexities of clinical trials, focusing on patient enrollment, retention challenges, and the importance of site activation. Suresh shares insights on the multifaceted nature of enrollment risks, the significance of building relationships with sites, and the innovative strategies being employed to enhance patient engagement and retention. The conversation also touches on the evolving role of technology in clinical operations and the need for companies to adapt to new advancements.